Role of transglutaminase 2 in apoptosis induced by hydrogen peroxide in human chondrocytes

Journal of Orthopaedic Research

Volumn 29, Issue 2, 2011, Pages 252-257

  Han, Ilkyu ^a   Park, Hee Jung ^a   Seong, Sang Cheol ^a   Lee, Sahnghoon ^a   Kim, In Gyu ^a   Lee, Myung Chul ^a  

^a Seoul National University   (South Korea)

Author keywords

apoptosis; chondrocyte; human; oxidative stress; transglutaminase 2

Indexed keywords

HYDROGEN PEROXIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOTAL KNEE REPLACEMENT;

APOPTOSIS; CELLS, CULTURED; CHONDROCYTES; GTP-BINDING PROTEINS; HUMANS; HYDROGEN PEROXIDE; TRANSGLUTAMINASES; UP-REGULATION;

EID: 78650955450     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21241     Document Type: Article

References (27)

1. Kuhn K, Lima DD, Hashimoto S, et al. 2004. Cell death in cartilage. Osteoarthritis Cartilage 11: 1-16.
2. Aigner T, Kim HA., 2002. Apoptosis and cellular vitality Issues in osteoarthrtitic cartilage degeneration. Arthritis Rheum 46: 1986-1996.
3. Wyllie AH, Kerr JFR, Currie AR., 1980. Cell death: The significance of apoptosis. Int Rev Cytol 68: 251-306.
4. Heraud F, Heraud A, Harmand MF., 2000. Apoptosis in normal and osteoarthritic human articular cartilage. Ann Rheum Dis 59: 959-965.
5. Matsuo M, Nishida K, Yoshida A, et al. 2001. Expression of caspase-3 and -9 relevant to cartilage destruction and chondrocyte apoptosis in human osteoarthritic cartilage. Acta Med Okayama 55: 333-340.
6. D'Lima DD, Hashimoto S, Chen PC, et al. 2001. Impact of mechanical trauma on matrix and cells. Clin Orthop 391: S90-S99.
7. Henrotin YE, Bruckner P, Pujol JP., 2003. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11: 747-755.
8. Lo MY, Kim HT., 2004. Chondrocyte apoptosis induced by hydrogen peroxide requires caspase activation but not mitochondrial pore transition. J Orthop Res 22: 1120-1125.
9. Lorand L, Graham RM., 2003. Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4: 140-156.
10. Fink ML, Chung SI, Folk. JE., 1980. gamma-Glutamylamine cyclotransferase: Specificity toward epsilon-(L-gamma-glutamyl)-L-lysine and related compounds. Proc Natl Acad Sci USA 77: 4564-4568.
11. Volokhina EB, Hulshof R, Haanen C, et al. 2003. Tissue transglutaminase mRNA expression in apoptotic cell death. Apoptosis 8: 673-679.
12. Johnson K, Hashimoto S, Lotz M, et al. 2001. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 159: 149-163.
13. Rosenthal AK, Derfus BA, Henry LA., 1997. Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum 40: 966-970.
14. Parameswaran KN, Velasco PT, Wilson J, et al. 1990. Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc Natl Acad Sci USA 87: 8472-8475.
15. Jeon JH, Jang GY, Kim CW, et al. 2004. Cell-based assay for monitoring transglutaminase activity. Anal Biochem 333: 399-401.
16. Balajthy Z, Csomos K, Vamosi G, et al. 2006. Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions. Blood 108: 2045-2054.
17. Maruko A, Ohtake Y, Konno K, et al. 2006. Transglutaminase differentially regulates growth signalling in rat perivenous and periportal hepatocytes. Cell Prolif 39: 183-193.
18. Rosenthal AK, Gohr CM, Uzuki M, et al. 2007. Osteopontin promotes pathologic mineralization in articular cartilage. Matrix Biol 26: 96-105.
19. Antonyak MA, Miller AM, Jansen JM, et al. 2004. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem 279: 41461-41467.
20. Boehm JE, Singh U, Combs C, et al. 2002. Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem 277: 20127-20130.
21. Ponnusamy M, Pang M, Annamaraju PK, et al. 2009. Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways. Am J Physiol Renal Physiol 297: F1361-F1370.
22. Yamaguchi H, Wang. HG., 2006. Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells. Mol Cell Biol 26: 569-579.
23. Elbashir SM, Harborth J, Lendeckel W, et al. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
24. Johnson KA, Rose DM, Terkeltaub RA., 2008. Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. J Cell Sci 121: 2256-2264.
25. Chuang DM., 1981. Inhibitors of transglutaminase prevent agonist-mediated internalization of beta-adrenergic receptors. J Biol Chem 256: 8291-8293.
26. Mishra S, Melino G, Murphy LJ., 2007. Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein. J Biol Chem 282: 18108-18115.
27. Mishra S, Murphy LJ., 2004. Tissue transglutaminase has intrinsic kinase activity: Identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem 279: 23863-23868.